Back to search

Article

Targeting TPO/MPL Signaling to Mitigate JAK2V617F-driven Cardiac Microvascular Disease

2026-04-03

Abstract excerpt

<h4>Background</h4> Individuals with JAK2V617F -mutant myeloproliferative neoplasms or clonal hematopoiesis of indeterminate potential have a markedly increased risk of cardiovascular disease, yet the mechanisms by which mutant blood cells drive vascular and cardiac dysfunction remain incompletely understood. Although the thrombopoietin (TPO) receptor MPL is central to hematopoiesis and is expressed in vascular...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a2156a4d-f599-5461-b0af-f275ae77542a
DOI
10.64898/2026.04.01.715884
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting TPO/MPL Signaling to Mitigate JAK2V617F-driven Cardiac Microvascular DiseaseDOI 10.64898/2026.04.01.715884
Select a neighboring publication to make it the new centre.